Omnicell Operating Margin 2010-2025 | OMCL

Current and historical operating margin for Omnicell (OMCL) over the last 10 years. The current operating profit margin for Omnicell as of June 30, 2025 is 4.64%.
Omnicell Operating Margin Historical Data
Date TTM Revenue TTM Operating Income Operating Margin
2025-06-30 $1.15B $0.02B 1.30%
2025-03-31 $1.14B $0.01B 0.88%
2024-12-31 $1.11B 0 0.00%
2024-09-30 $1.06B $-0.04B -3.29%
2024-06-30 $1.08B $-0.04B -3.52%
2024-03-31 $1.10B $-0.03B -2.99%
2023-12-31 $1.15B $-0.03B -2.96%
2023-09-30 $1.19B $-0.05B -4.13%
2023-06-30 $1.24B $-0.04B -2.83%
2023-03-31 $1.27B $-0.03B -2.44%
2022-12-31 $1.30B $0.00B -0.23%
2022-09-30 $1.31B $0.05B 3.59%
2022-06-30 $1.26B $0.06B 4.61%
2022-03-31 $1.20B $0.08B 6.26%
2021-12-31 $1.13B $0.09B 7.95%
2021-09-30 $1.07B $0.10B 9.16%
2021-06-30 $0.99B $0.08B 8.00%
2021-03-31 $0.92B $0.04B 4.70%
2020-12-31 $0.89B $0.04B 3.92%
2020-09-30 $0.89B $0.04B 4.15%
2020-06-30 $0.91B $0.05B 5.73%
2020-03-31 $0.92B $0.08B 8.44%
2019-12-31 $0.90B $0.08B 8.81%
2019-09-30 $0.86B $0.08B 8.83%
2019-06-30 $0.84B $0.07B 8.13%
2019-03-31 $0.81B $0.06B 6.93%
2018-12-31 $0.79B $0.04B 5.58%
2018-09-30 $0.77B $0.04B 5.31%
2018-06-30 $0.76B $0.04B 4.77%
2018-03-31 $0.75B $0.03B 3.75%
2017-12-31 $0.71B $0.01B 1.40%
2017-09-30 $0.69B $0.01B 1.30%
2017-06-30 $0.68B $0.00B 0.29%
2017-03-31 $0.67B $0.00B 0.45%
2016-12-31 $0.70B $0.02B 3.16%
2016-09-30 $0.65B $0.02B 2.92%
2016-06-30 $0.60B $0.03B 4.67%
2016-03-31 $0.54B $0.04B 7.42%
2015-12-31 $0.48B $0.05B 9.92%
2015-09-30 $0.48B $0.05B 10.29%
2015-06-30 $0.46B $0.05B 10.56%
2015-03-31 $0.46B $0.05B 10.96%
2014-12-31 $0.44B $0.05B 11.31%
2014-09-30 $0.43B $0.05B 11.27%
2014-06-30 $0.41B $0.05B 11.06%
2014-03-31 $0.40B $0.04B 10.35%
2013-12-31 $0.38B $0.04B 9.19%
2013-09-30 $0.37B $0.03B 9.32%
2013-06-30 $0.36B $0.03B 9.58%
2013-03-31 $0.34B $0.03B 8.04%
2012-12-31 $0.31B $0.03B 8.63%
2012-09-30 $0.29B $0.02B 8.04%
2012-06-30 $0.27B $0.02B 6.39%
2012-03-31 $0.25B $0.02B 7.54%
2011-12-31 $0.25B $0.02B 6.53%
2011-09-30 $0.24B $0.01B 5.02%
2011-06-30 $0.23B $0.01B 4.33%
2011-03-31 $0.23B $0.01B 4.00%
2010-12-31 $0.22B $0.01B 4.50%
2010-09-30 $0.22B $0.01B 4.09%
2010-06-30 $0.22B $0.01B 3.21%
2010-03-31 $0.22B $0.01B 2.31%
2009-12-31 $0.21B 0 0.00%
Sector Industry Market Cap Revenue
Medical Medical Information Systems $1.394B $1.112B
Omnicell Inc., develops and markets end-to-end automation solutions for the medication-use process. These automation solutions contain medication and supply dispensing systems, central pharmacy storage, retrieval and packaging solutions, a bedside automation solution, a physician order management solution, a decision support application, and a Web-based procurement application. The products offered by the company enable care providers to improve patient safety and increase efficiency by lowering costs. The company also adheres to regulatory compliances and addresses issues related to population health.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $45.976B 58.49
Hims & Hers Health (HIMS) United States $14.001B 145.47
Doximity (DOCS) United States $10.768B 49.85
Tempus AI (TEM) United States $9.502B 0.00
IRhythm Technologies (IRTC) United States $5.267B 0.00
Inspire Medical Systems (INSP) United States $3.719B 58.11
Hinge Health (HNGE) United States $3.507B 0.00
Privia Health (PRVA) United States $2.299B 157.17
10x Genomics (TXG) United States $1.611B 0.00
Phreesia (PHR) United States $1.567B 0.00
Azenta (AZTA) United States $1.481B 68.81
Enovis (ENOV) United States $1.470B 8.20
Schrodinger (SDGR) United States $1.433B 0.00
Clover Health Investments (CLOV) United States $1.415B 0.00
Evolent Health (EVH) United States $1.172B 99.80
Claritev (CTEV) United States $0.632B 0.00
Fulgent Genetics (FLGT) United States $0.564B 0.00
Veradigm (MDRX) United States $0.525B 0.00
Standard BioTools (LAB) United States $0.494B 0.00
Talkspace (TALK) United States $0.387B 115.50
Butterfly Network (BFLY) United States $0.346B 0.00
TruBridge (TBRG) United States $0.309B 684.67
Outset Medical (OM) United States $0.267B 0.00
Nyxoah SA (NYXH) Belgium $0.249B 0.00
Health Catalyst (HCAT) United States $0.245B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.211B 0.00
Zepp Health (ZEPP) Netherlands $0.188B 0.00
CapsoVision (CV) United States $0.181B 0.00
KORU Medical Systems (KRMD) United States $0.161B 0.00
EUDA Health Holdings (EUDA) Singapore $0.118B 0.00
MDxHealth SA (MDXH) Belgium $0.115B 0.00
American Well (AMWL) United States $0.109B 0.00
CareCloud (CCLD) United States $0.098B 3.73
ImmunoPrecise Antibodies (IPA) Canada $0.076B 0.00
Insight Molecular Diagnostics (IMDX) United States $0.073B 0.00
Pulmonx (LUNG) United States $0.065B 0.00
111 (YI) China $0.060B 0.00
P3 Health Partners (PIII) United States $0.053B 0.00
HeartBeam (BEAT) United States $0.034B 0.00
Zhongchao (ZCMD) China $0.025B 0.00
Streamline Health Solutions (STRM) United States $0.023B 0.00
Precipio (PRPO) United States $0.022B 0.00
Bullfrog AI Holdings (BFRG) United States $0.012B 0.00
Strata Skin Sciences (SSKN) United States $0.008B 0.00
Predictive Oncology (POAI) United States $0.008B 0.00
Healthcare Triangle (HCTI) United States $0.008B 0.00
MSP Recovery (MSPR) United States $0.008B 0.00
HeartSciences (HSCS) United States $0.007B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.005B 0.00
Movano (MOVE) United States $0.004B 0.00
Evaxion - (EVAX) Denmark $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
PROFUSA (PFSA) United States $0.003B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00